Voskuyl, A., Van Duinen, S. G, Zwinderman, A., Breedveld, F., Hazes, J.
OBJECTIVE—To determine the diagnostic value of perivascular infiltrates (PVI) in randomly obtained muscle biopsy specimens for the assessment of rheumatoid vasculitis (RV). METHODS—The number...
Verschueren, P., Voskuyl, A., Smeets, T, Zwinderman, K., Breedveld, F., Tak, P.
OBJECTIVE—Histological analysis of random quadriceps muscle biopsy specimens can be used to detect vasculitis in patients with rheumatoid arthritis (RA). This study aimed at determining the...
Influence of HLA polymorphism on persistent remission in rheumatoid arthritis
Molenaar, E, Voskuyl, A, Schreuder, G, Zanelli, E, Dijkmans, B
Objective: To determine the distribution of HLA-DRB1 and DQB1/DQA1 alleles in a cohort of patients with RA in remission and to determine the association between these HLA alleles and the persistence...
Diagnostic strategy for the assessment of rheumatoid vasculitis
Voskuyl, A, Hazes, J, Zwinderman, A, Paleolog, E, Daha, M, ...
Objective: To determine the clinical features associated with histologically proven rheumatoid vasculitis (HRV) and the additional diagnostic value of serological markers in an inception cohort of 81...
Boers, M, Nurmohamed, M, Doelman, C, Lard, L, Verhoeven, A, Voskuyl, A, ...
Background: Glucocorticoids induce hypercholesterolaemia, a cardiovascular risk factor, in patients with diseases other than rheumatoid arthritis (RA), but the data in RA are contradictory.
Lodder, M, De Jong, Z, Kostense, P, Molenaar, E, Staal, K, Voskuyl, A, ...
Objective: To examine variables associated with bone mineral density (BMD) in patients with rheumatoid arthritis (RA).
Bone mineral density in patients with rheumatoid arthritis treated with infliximab
Vis, M, Voskuyl, A, Wolbink, G, Dijkmans, B, Lems, W, T For,
Neven, N, Vis, M, Voskuyl, A, Wolbink, G, Nurmohamed, M, Dijkmans, B, ...
Wolbink, G, Voskuyl, A, Lems, W, De Groot, E, Nurmohamed, M, Tak, P, ...
Objective: To investigate the relationship between serum trough infliximab levels and clinical response to infliximab treatment in patients with rheumatoid arthritis (RA).
Infliximab treatment reduces complement activation in patients with rheumatoid arthritis
Familian, A, Voskuyl, A, Van Mierlo, G J, Heijst, H, Twisk, J, Dijkmans, B, ...
Background: Tumour necrosis factor (TNF) blocking agents decrease C reactive protein (CRP) levels in rheumatoid arthritis (RA). It has been shown that CRP may contribute to complement activation in...
Bultink, I, Teerlink, T, Heijst, J, Dijkmans, B, Voskuyl, A
Objective: To investigate the relationship between plasma ADMA levels and cardiovascular events (CVEs) and disease characteristics in patients with systemic lupus erythematosus (SLE).